To meet the challenges of the ever-changing and developing world, Orchev has since the beginning given the emphasis on R&D. Our main focus remains on improving processes to obtain excellent quality material, Maximum yield, minimize pollution, and less energy & water requirement.
Since September 2014, Orchev took the next step in its growth by setting up a separate R&D team. The team is headed by scientist have several years of experience in Pharma Research. R&D Teams’ main focus is to develop a process for the product of Orchev’s interest.
Our R&D team is working to add new products to our API portfolio. Famotidine, Allopurinol, and Levetiracetam are the APIs our team has been working on since November 2019.
We now also pose capabilities to develop a process for custom synthesis for products of the client interest. We are looking for customers and partners who can utilize our expertise in high vacuum distillation, API with regulatory documents, handling of Hazardous chemicals like Sodium thiomethoxide, and personalized services.